Showing results (171-180 of 588) with videos related to
Sort By:
Pageof 59
Arthritis Research & Therapy|May 4, 2013
What can rheumatologists learn from translational cancer therapy?Jonathan P Sherlock, Andrew D Filer, John D Isaacs, et al.International Journal of Geriatric Psychiatry|July 24, 2023
Has COVID-19 affected dementia diagnosis rates in England?Jemma Hazan, Kathy Y Liu, Jeremy D Isaacs, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1988
Wound infection with aerogenic Aeromonas strains: a review of twenty-seven casesR D Isaacs, S D Paviour, D E Bunker, et al.Journal of Internal Medicine|September 26, 2015
Biosimilars in immune-mediated inflammatory diseases: initial lessons from the first approved biosimilar anti-tumour necrosis factor monoclonal antibodyJ D Isaacs, M Cutolo, E C Keystone, et al.Lancet (London, England)|June 26, 1993
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapyC M Lockwood, S Thiru, J D Isaacs, et al.Family Practice|June 1, 1987
Patient use of a paediatric hospital casualty department in the east end of LondonA Bowling, D Isaacs, J Armston, et al.Journal of Paediatrics and Child Health|March 4, 1998
Complications of central venous access devices in children with and without cancerR Tobiansky, K Lui, D M Dalton, et al.Clinical and Experimental Rheumatology|March 1, 1993
CAMPATH-1H in inflammatory arthritisR A Watts, J D Isaacs, G Hale, et al.Molecular and Cellular Biology|December 24, 2008
Postrecruitment regulation of RNA polymerase II directs rapid signaling responses at the promoters of estrogen target genesMiltiadis Kininis, Gary D Isaacs, Leighton J Core, et al.Annals of the Rheumatic Diseases|September 24, 2009
Tumour necrosis factor alpha blockade impairs dendritic cell survival and function in rheumatoid arthritisHelen M Baldwin, Toshiko Ito-Ihara, John D Isaacs, et al.Pageof 59